Dyslipidemia and inflammation: an evolutionary conserved mechanism.

[1]  T. Tachikawa,et al.  Subcutaneous and continuous administration of lipopolysaccharide increases serum levels of triglyceride and monocyte chemoattractant protein-1 in rats. , 2004, Journal of periodontal research.

[2]  Z. Varghese,et al.  Regulation of lipoprotein trafficking in the kidney: role of inflammatory mediators and transcription factors. , 2004, Biochemical Society transactions.

[3]  N. Powe,et al.  Association between cholesterol level and mortality in dialysis patients: role of inflammation and malnutrition. , 2004, JAMA.

[4]  J. Sundvall,et al.  Periodontitis decreases the antiatherogenic potency of high density lipoprotein Published, JLR Papers in Press, September 16, 2003. DOI 10.1194/jlr.M300250-JLR200 , 2004, Journal of Lipid Research.

[5]  C. Vrints,et al.  Association of lipoproteins with cytokines and cytokine receptors in heart failure patients. Differences between ischaemic versus idiopathic cardiomyopathy. , 2003, European heart journal.

[6]  R. Munford,et al.  Acute inflammation and infection maintain circulating phospholipid levels and enhance lipopolysaccharide binding to plasma lipoproteins Published, JLR Papers in Press, August 16, 2003. DOI 10.1194/jlr.M300228-JLR200 , 2003, Journal of Lipid Research.

[7]  G. Cheng,et al.  Crosstalk between LXR and toll-like receptor signaling mediates bacterial and viral antagonism of cholesterol metabolism. , 2003, Molecular cell.

[8]  Harvey F Lodish,et al.  Insulin resistance in adipose tissue: direct and indirect effects of tumor necrosis factor-alpha. , 2003, Cytokine & growth factor reviews.

[9]  L. Appel,et al.  Inflammation Modifies the Effects of a Reduced-Fat Low-Cholesterol Diet on Lipids: Results From the DASH-Sodium Trial , 2003, Circulation.

[10]  A. Hamsten,et al.  TNF-α: a link between hypertriglyceridaemia and inflammation in SLE patients with cardiovascular disease , 2003 .

[11]  M. Cramer,et al.  Adult-onset growth hormone deficiency: Relation of postprandial dyslipidemia to premature atherosclerosis. , 2003, The Journal of clinical endocrinology and metabolism.

[12]  J. Fernández-Real,et al.  Insulin resistance and chronic cardiovascular inflammatory syndrome. , 2003, Endocrine reviews.

[13]  D. Mangelsdorf,et al.  Liver X receptor signaling pathways in cardiovascular disease. , 2003, Molecular endocrinology.

[14]  A. Zwinderman,et al.  Variants of Toll-Like Receptor 4 Modify the Efficacy of Statin Therapy and the Risk of Cardiovascular Events , 2003, Circulation.

[15]  B. Zahorska-Markiewicz,et al.  Hyperlipidaemias and serum cytokines in patients with coronary artery disease , 2003, Acta cardiologica.

[16]  J. Parrillo,et al.  Protein-free phospholipid emulsion treatment improved cardiopulmonary function and survival in porcine sepsis. , 2003, American journal of physiology. Regulatory, integrative and comparative physiology.

[17]  H. Harris,et al.  Induction of Cytokine Tolerance in Rodent Hepatocytes by Chylomicron-Bound LPS is Low-Density Lipoprotein Receptor Dependent , 2003, Shock.

[18]  M. Taskinen,et al.  Insulin resistance and adiposity correlate with acute-phase reaction and soluble cell adhesion molecules in type 2 diabetes. , 2003, Atherosclerosis.

[19]  A. Dembińska-kieć,et al.  The TNF- α Gene NcoI Polymorphism at Position –308 of the Promoter Influences Insulin Resistance, and Increases Serum Triglycerides after Postprandial Lipaemia in Familiar Obesity , 2003, Clinical chemistry and laboratory medicine.

[20]  P. Libby.  Inflammation in atherosclerosis , 2002, Nature.

[21]  H. Shimano,et al.  Lipolysis in the absence of hormone-sensitive lipase: evidence for a common mechanism regulating distinct lipases. , 2002, Diabetes.

[22]  B. Çakır,et al.  Plasma Tumor Necrosis Factor-Alpha Levels and Insulin Resistance in Nondiabetic Hypertensive Subjects , 2002, Hormone Research in Paediatrics.

[23]  D. Mangelsdorf,et al.  The liver X receptor gene team: Potential new players in atherosclerosis , 2002, Nature Medicine.

[24]  T. Golub,et al.  Profiling gene transcription in vivo reveals adipose tissue as an immediate target of tumor necrosis factor-alpha: implications for insulin resistance. , 2002, Diabetes.

[25]  J. Oram.  ATP-binding cassette transporter A1 and cholesterol trafficking , 2002, Current opinion in lipidology.

[26]  D. Rader,et al.  Human Secretory Phospholipase A2 Mediates Decreased Plasma Levels of HDL Cholesterol and ApoA-I in Response to Inflammation in Human ApoA-I Transgenic Mice , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[27]  A. Remaley,et al.  Lipopolysaccharide Down Regulates Both Scavenger Receptor B1 and ATP Binding Cassette Transporter A1 in RAW Cells , 2002, Infection and Immunity.

[28]  A. Vasku,et al.  Polymorphism Ncol in tumor necrosis factor B is associated with fasting glycemia and lipid parameters in healthy non-obese caucasian subjects. , 2002, Diabetes & metabolism.

[29]  T. Willson,et al.  Synthetic LXR ligand inhibits the development of atherosclerosis in mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[30]  G. Paolisso,et al.  Postprandial endothelial activation in healthy subjects and in type 2 diabetic patients: role of fat and carbohydrate meals. , 2002, Journal of the American College of Cardiology.

[31]  A. D. de Craen,et al.  Low production capacity of interleukin-10 associates with the metabolic syndrome and type 2 diabetes : the Leiden 85-Plus Study. , 2002, Diabetes.

[32]  G. Hansson,et al.  Expression of Toll-Like Receptors in Human Atherosclerotic Lesions: A Possible Pathway for Plaque Activation , 2002, Circulation.

[33]  A. Hamsten,et al.  Plasma tumour necrosis factor-alpha and early carotid atherosclerosis in healthy middle-aged men. , 2002, European heart journal.

[34]  R. Westendorp,et al.  Severe hypertriglyceridemia with insulin resistance is associated with systemic inflammation: reversal with bezafibrate therapy in a randomized controlled trial. , 2002, The American journal of medicine.

[35]  H. Harris,et al.  Endogenous lipoproteins impact the response to endotoxin in humans , 2002, Critical care medicine.

[36]  N. Christeff,et al.  Increased serum interferon alpha in HIV–1 associated lipodystrophy syndrome , 2002, European journal of clinical investigation.

[37]  Z. Varghese,et al.  Dysregulation of LDL receptor under the influence of inflammatory cytokines: a new pathway for foam cell formation. , 2001, Kidney international.

[38]  Y. T. Lee,et al.  Differential lipogenic effects of cilostazol and pentoxifylline in patients with intermittent claudication: potential role for interleukin-6. , 2001, Atherosclerosis.

[39]  A. V. van Beek,et al.  The role of high density lipoprotein in sepsis. , 2001 .

[40]  K. Yano,et al.  Cholesterol and all-cause mortality in elderly people from the Honolulu Heart Program: a cohort study , 2001, The Lancet.

[41]  P. Barie,et al.  Relationship of hypolipidemia to cytokine concentrations and outcomes in critically ill surgical patients , 2001, Critical care medicine.

[42]  Deventer,et al.  Distribution and Kinetics of Lipoprotein-Bound Endotoxin , 2001, Infection and Immunity.

[43]  B. Morris,et al.  Tumor necrosis factor receptor 2 gene (TNFRSF1B) in genetic basis of coronary artery disease , 2001, Journal of Molecular Medicine.

[44]  C. Higgins,et al.  ABC transporters: physiology, structure and mechanism--an overview. , 2001, Research in microbiology.

[45]  B. Morris,et al.  TNFRSF1B in genetic predisposition to clinical neuropathy and effect on HDL cholesterol and glycosylated hemoglobin in type 2 diabetes. , 2001, Diabetes care.

[46]  W. Buurman,et al.  LPS-binding protein circulates in association with apoB-containing lipoproteins and enhances endotoxin-LDL/VLDL interaction. , 2001, The Journal of clinical investigation.

[47]  K. Rye,et al.  Influence of phospholipid depletion on the size, structure, and remodeling of reconstituted high density lipoproteins. , 2000, Journal of lipid research.

[48]  J. Rotter,et al.  Identification of TNFRSF1B as a novel modifier gene in familial combined hyperlipidemia. , 2000, Human molecular genetics.

[49]  B. Morris,et al.  Linkage and association of tumor necrosis factor receptor 2 locus with hypertension, hypercholesterolemia and plasma shed receptor. , 2000, Human molecular genetics.

[50]  K. Feingold,et al.  Infection and inflammation induce LDL oxidation in vivo. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[51]  K. Feingold,et al.  Infection and inflammation-induced proatherogenic changes of lipoproteins. , 2000, The Journal of infectious diseases.

[52]  D. Rader,et al.  Overexpression of Secretory Phospholipase A2 Causes Rapid Catabolism and Altered Tissue Uptake of High Density Lipoprotein Cholesteryl Ester and Apolipoprotein A-I* , 2000, The Journal of Biological Chemistry.

[53]  D. Papanicolaou,et al.  Interleukin-6 gene polymorphism and lipid abnormalities in healthy subjects. , 2000, The Journal of clinical endocrinology and metabolism.

[54]  G. Lippi,et al.  Lipoprotein(a): from ancestral benefit to modern pathogen? , 2000, QJM : monthly journal of the Association of Physicians.

[55]  A. Weverling-Rijnsburger,et al.  Hyperlipoproteinemia affects cytokine production in whole blood samples ex vivo. The influence of lipid-lowering therapy. , 2000, Atherosclerosis.

[56]  S. Humphries,et al.  Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? , 2000, Atherosclerosis.

[57]  A. Hamsten,et al.  LDL particle size distribution is associated with carotid intima-media thickness in healthy 50-year-old men. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[58]  W. Ricart,et al.  Plasma levels of the soluble fraction of tumor necrosis factor receptors 1 and 2 are independent determinants of plasma cholesterol and LDL-cholesterol concentrations in healthy subjects. , 1999, Atherosclerosis.

[59]  K. Kugiyama,et al.  Circulating levels of secretory type II phospholipase A(2) predict coronary events in patients with coronary artery disease. , 1999, Circulation.

[60]  S. Hazen,et al.  The Oxidation of Lipoproteins by Monocytes-Macrophages , 1999, The Journal of Biological Chemistry.

[61]  A. J. Millis,et al.  Clusterin (Apo J) regulates vascular smooth muscle cell differentiation in vitro , 1999, Journal of cellular physiology.

[62]  J. Qiao,et al.  Role of group II secretory phospholipase A2 in atherosclerosis: 2. Potential involvement of biologically active oxidized phospholipids. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[63]  S. Coppack,et al.  C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[64]  D. Rader,et al.  Expression of serum amyloid A protein in the absence of the acute phase response does not reduce HDL cholesterol or apoA-I levels in human apoA-I transgenic mice. , 1999, Journal of lipid research.

[65]  A. Tall,et al.  Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels. , 1999, The Journal of clinical investigation.

[66]  K. Feingold,et al.  Endotoxin and interleukin-1 decrease hepatic lipase mRNA levels. , 1999, Atherosclerosis.

[67]  C. Wanner,et al.  Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. , 1999, Kidney international.

[68]  P. Durrington.  Triglycerides are more important in atherosclerosis than epidemiology has suggested. , 1998, Atherosclerosis.

[69]  A. Gotto.  Triglyceride as a risk factor for coronary artery disease. , 1998, The American journal of cardiology.

[70]  K. Feingold,et al.  Paraoxonase activity in the serum and hepatic mRNA levels decrease during the acute phase response. , 1998, Atherosclerosis.

[71]  K. Feingold,et al.  Endotoxin and cytokines increase hepatic sphingolipid biosynthesis and produce lipoproteins enriched in ceramides and sphingomyelin. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[72]  D. Shih,et al.  Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis , 1998, Nature.

[73]  J. L. Carrillo,et al.  Lipoprotein alterations in patients with HIV infection: relation with cellular and humoral immune markers. , 1998, Clinica chimica acta; international journal of clinical chemistry.

[74]  R. Ramharack,et al.  Dominant Negative Effect of TGF-β1 and TNF-α on Basal and IL-6–Induced Lipoprotein(a) and Apolipoprotein(a) mRNA Expression in Primary Monkey Hepatocyte Cultures , 1998 .

[75]  Z. Varghese,et al.  Cytokine regulation of low-density lipoprotein receptor gene transcription in human mesangial cells. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[76]  B. La Du,et al.  Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. , 1998, The Journal of clinical investigation.

[77]  H. Hauner,et al.  Tumor necrosis factor-alpha acutely inhibits insulin signaling in human adipocytes: implication of the p80 tumor necrosis factor receptor. , 1998, Diabetes.

[78]  H. Hein,et al.  Triglyceride concentration and ischemic heart disease: an eight-year follow-up in the Copenhagen Male Study. , 1998, Circulation.

[79]  G. Lippi,et al.  Modification of serum apolipoprotein A-I, apolipoprotein B and lipoprotein(a) levels after bisphosphonates-induced acute phase response. , 1998, Clinica chimica acta; international journal of clinical chemistry.

[80]  H. Phetteplace,et al.  SEQUENTIAL ALTERATIONS IN TISSUE LIPOPROTEIN LIPASE, TRIGLYCERIDE SECRETION RATES, AND SERUM TUMOR NECROSIS FACTOR α DURING ESCHERICHIA COLI BACTEREMIC SEPSIS IN RELATION TO THE DEVELOPMENT OF HYPERTRIGLYCERIDEMIA , 1998, Shock.

[81]  E. Rubin,et al.  Lipoprotein(a) vascular accumulation in mice. In vivo analysis of the role of lysine binding sites using recombinant adenovirus. , 1997, The Journal of clinical investigation.

[82]  A J Mendez,et al.  Cholesterol efflux mediated by apolipoproteins is an active cellular process distinct from efflux mediated by passive diffusion. , 1997, Journal of lipid research.

[83]  D. Strachan,et al.  Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease. , 1997, Heart.

[84]  Daniel Steinberg,et al.  Low Density Lipoprotein Oxidation and Its Pathobiological Significance* , 1997, The Journal of Biological Chemistry.

[85]  L. Paka,et al.  Subendothelial retention of lipoprotein (a). Evidence that reduced heparan sulfate promotes lipoprotein binding to subendothelial matrix. , 1997, The Journal of clinical investigation.

[86]  J. Fernández-Real,et al.  The TNF-β Gene Nco I Polymorphism Is Not Associated with Hypertriglyceridemia or Insulin Resistance in Lean and Obese Subjects☆ , 1997 .

[87]  A. Lusis,et al.  Overexpression of apolipoprotein AII in transgenic mice converts high density lipoproteins to proinflammatory particles. , 1997, The Journal of clinical investigation.

[88]  D. Rader,et al.  Defensin stimulates the binding of lipoprotein (a) to human vascular endothelial and smooth muscle cells. , 1997, Blood.

[89]  J. Kuiper,et al.  Human recombinant apolipoprotein E redirects lipopolysaccharide from Kupffer cells to liver parenchymal cells in rats In vivo. , 1997, The Journal of clinical investigation.

[90]  W. Samlowski,et al.  Acute dyslipoproteinemia induced by interleukin-2: lecithin:cholesteryl acyltransferase, lipoprotein lipase, and hepatic lipase deficiencies. , 1997, The Journal of clinical endocrinology and metabolism.

[91]  M. Wurfel,et al.  Lipopolysaccharide-binding protein and soluble CD14 transfer lipopolysaccharide to phospholipid bilayers: preferential interaction with particular classes of lipid. , 1997, Journal of immunology.

[92]  K. Feingold,et al.  LPS and cytokines regulate extra hepatic mRNA levels of apolipoproteins during the acute phase response in Syrian hamsters. , 1997, Biochimica et biophysica acta.

[93]  S. Yokoyama,et al.  Apolipoprotein-mediated removal of cellular cholesterol and phospholipids. , 1996, Journal of lipid research.

[94]  S. Rantapää-Dahlqvist,et al.  Lipoprotein lipase in relation to inflammatory activity in rheumatoid arthritis , 1996, Journal of internal medicine.

[95]  J. E. Doran,et al.  Antiinflammatory effects of reconstituted high-density lipoprotein during human endotoxemia , 1996, The Journal of experimental medicine.

[96]  R. Krauss,et al.  Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. , 1996, JAMA.

[97]  J. Romijn,et al.  Endocrine and metabolic effects of interferon-alpha in humans. , 1996, The Journal of clinical endocrinology and metabolism.

[98]  P. Lerch,et al.  Production and Characterization ofa Reconstituted High Density Lipoprotein for Therapeutic Applications , 1996, Vox sanguinis.

[99]  T. Hughes,et al.  Differential regulation of lipoprotein lipase in the macrophage J774.2 cell line by cytokines. , 1996, Cytokine.

[100]  M. Lopes-Virella,et al.  Cytokines, Modified Lipoproteins, and Arteriosclerosis in Diabetes , 1996, Diabetes.

[101]  K. Feingold,et al.  Endotoxin and cytokines decrease serum levels and extra hepatic protein and mRNA levels of cholesteryl ester transfer protein in syrian hamsters. , 1996, The Journal of clinical investigation.

[102]  D. Rader,et al.  Unravelling high density lipoprotein-apolipoprotein metabolism in human mutants and animal models , 1996, Current opinion in lipidology.

[103]  D. Stafforini,et al.  Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures. , 1995, The Journal of clinical investigation.

[104]  R. Kirchmair,et al.  Postprandial state and atherosclerosis , 1995, Current opinion in lipidology.

[105]  X. Jiang,et al.  Regulation of Murine Plasma Phospholipid Transfer Protein Activity and mRNA Levels by Lipopolysaccharide and High Cholesterol Diet (*) , 1995, The Journal of Biological Chemistry.

[106]  P. Vadas,et al.  Serum amyloid A protein enhances the activity of secretory non-pancreatic phospholipase A2. , 1995, The Biochemical journal.

[107]  K. Feingold,et al.  Discordant regulation of proteins of cholesterol metabolism during the acute phase response. , 1995, Journal of lipid research.

[108]  K. Feingold,et al.  Triglyceride-rich lipoproteins prevent septic death in rats , 1995, The Journal of experimental medicine.

[109]  K. Feingold,et al.  Endotoxin and TNF lead to reduced plasma LCAT activity and decreased hepatic LCAT mRNA levels in Syrian hamsters. , 1995, Journal of lipid research.

[110]  C. Gutiérrez,et al.  A tumor necrosis factor-β polymorphism associated with hypertriglyceridemia in non-insulin-dependent diabetes mellitus☆ , 1995 .

[111]  T. van der Poll,et al.  Endocrinologic and metabolic effects of interleukin-6 in humans. , 1995, The American journal of physiology.

[112]  K. Feingold,et al.  Interleukin-6 stimulates hepatic triglyceride secretion in rats. , 1995, Endocrinology.

[113]  A. Tall,et al.  Decreased cholesteryl ester transfer protein (CETP) mRNA and protein and increased high density lipoprotein following lipopolysaccharide administration in human CETP transgenic mice. , 1995, The Journal of clinical investigation.

[114]  Toshiyuki Yamada.  [Serum amyloid A (SAA)]. , 1995, Nihon rinsho. Japanese journal of clinical medicine.

[115]  C. C. Coffin,et al.  Reconstituted high-density lipoprotein neutralizes gram-negative bacterial lipopolysaccharides in human whole blood , 1995, Infection and immunity.

[116]  K. Feingold,et al.  Cytokines induce catabolic effects in cultured adipocytes by multiple mechanisms. , 1994, Cytokine.

[117]  K. Feingold,et al.  Endotoxin and cytokines increase hepatic messenger RNA levels and serum concentrations of apolipoprotein J (clusterin) in Syrian hamsters. , 1994, The Journal of clinical investigation.

[118]  K. Feingold,et al.  Effects of endotoxin and cytokines on lipid metabolism. , 1994, Current opinion in lipidology.

[119]  K. Feingold,et al.  Effects of TNF, IL-1, and the combination of both cytokines on cholesterol metabolism in Syrian hamsters. , 1994, Lymphokine and cytokine research.

[120]  S. Eisenberg,et al.  Human HDL cholesterol levels are determined by apoA-I fractional catabolic rate, which correlates inversely with estimates of HDL particle size. Effects of gender, hepatic and lipoprotein lipases, triglyceride and insulin levels, and body fat distribution. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[121]  G. Chisolm,et al.  Intact human ceruloplasmin oxidatively modifies low density lipoprotein. , 1994, The Journal of clinical investigation.

[122]  J. Dipiro,et al.  Reconstituted high density lipoprotein inhibits physiologic and tumor necrosis factor α responses to lipopolysaccharide in rabbits , 1994 .

[123]  David B. Leake,et al.  Acidic pH enables caeruloplasmin to catalyse the modification of low‐density lipoprotein , 1994, FEBS letters.

[124]  J. Bush,et al.  Molecular cloning and characterization of the full-length cDNA encoding the developmentally regulated lysosomal enzyme beta-glucosidase in Dictyostelium discoideum. , 1994, The Journal of biological chemistry.

[125]  A. Walsh,et al.  In vivo protection against endotoxin by plasma high density lipoprotein. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[126]  T. Nevalainen.  Serum phospholipases A2 in inflammatory diseases. , 1993, Clinical chemistry.

[127]  J. Taylor,et al.  Effect of endotoxin on cholesterol biosynthesis and distribution in serum lipoproteins in Syrian hamsters. , 1993, Journal of lipid research.

[128]  H. Northoff,et al.  Prevention of endotoxin-induced monokine release by human low- and high-density lipoproteins and by apolipoprotein A-I , 1993, Infection and immunity.

[129]  J. Raynes,et al.  Serum amyloid A (SAA): an acute phase protein and apolipoprotein. , 1993, Atherosclerosis.

[130]  H. Harris,et al.  Chylomicrons enhance endotoxin excretion in bile , 1993, Infection and immunity.

[131]  R. Krauss,et al.  The hypertriglyceridemia of acquired immunodeficiency syndrome is associated with an increased prevalence of low density lipoprotein subclass pattern B. , 1993, The Journal of clinical endocrinology and metabolism.

[132]  K. Feingold,et al.  Tumor necrosis factor mediates the effects of endotoxin on cholesterol and triglyceride metabolism in mice. , 1993, Endocrinology.

[133]  J. E. Doran,et al.  A reconstituted, apolipoprotein A-I containing lipoprotein reduces tumor necrosis factor release and attenuates shock in endotoxemic rabbits. , 1993, Circulatory shock.

[134]  C. Grunfeld,et al.  Increased de novo hepatic lipogenesis in human immunodeficiency virus infection. , 1993, The Journal of clinical endocrinology and metabolism.

[135]  H. Harris,et al.  Chylomicrons alter the fate of endotoxin, decreasing tumor necrosis factor release and preventing death. , 1993, The Journal of clinical investigation.

[136]  R. Lawn,et al.  5' control regions of the apolipoprotein(a) gene and members of the related plasminogen gene family. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[137]  K. Feingold,et al.  Endotoxin rapidly induces changes in lipid metabolism that produce hypertriglyceridemia: low doses stimulate hepatic triglyceride production while high doses inhibit clearance. , 1992, Journal of lipid research.

[138]  C. Sweep,et al.  Chronic intraperitoneal infusion of low doses of tumor necrosis factor alpha in rats induces a reduction in plasma triglyceride levels. , 1992, Cytokine.

[139]  E. Gherardi,et al.  Transforming growth factor-β1 and interleukin-1β stimulate LDL receptor activity in Hep G2 cells , 1992 .

[140]  W. Ettinger,et al.  Effect of interleukin-1 alpha on lipoprotein lipids in cynomolgus monkeys: comparison to tumor necrosis factor. , 1992, Biochimica et biophysica acta.

[141]  K. Feingold,et al.  In vivo effects of interferon-alpha and interferon-gamma on lipolysis and ketogenesis. , 1992, Endocrinology.

[142]  S. Zuckerman,et al.  Cytokine regulation of macrophage apo E secretion: opposing effects of GM-CSF and TGF-beta. , 1992, Atherosclerosis.

[143]  S. Yusuf,et al.  Report of the Conference on Low Blood Cholesterol: Mortality Associations , 1992, Circulation.

[144]  C. Sweep,et al.  Continuous infusion of interleukin-1 beta in rats induces a profound fall in plasma levels of cholesterol and triglycerides. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[145]  R. Nordan,et al.  Interleukin 6 reduces lipoprotein lipase activity in adipose tissue of mice in vivo and in 3T3-L1 adipocytes: a possible role for interleukin 6 in cancer cachexia. , 1992, Cancer research.

[146]  J P Kane,et al.  Binding of transition metals by apolipoprotein A-I-containing plasma lipoproteins: inhibition of oxidation of low density lipoproteins. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[147]  K. Feingold,et al.  Cytokines stimulate lipolysis and decrease lipoprotein lipase activity in cultured fat cells by a prostaglandin independent mechanism. , 1992, Biochemical and biophysical research communications.

[148]  L. Subrahmanyan,et al.  Serum amyloid A changes high density lipoprotein's cellular affinity. A clue to serum amyloid A's principal function. , 1992, Laboratory investigation; a journal of technical methods and pathology.

[149]  K. Feingold,et al.  Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. , 1992, The Journal of clinical endocrinology and metabolism.

[150]  Y. Yang,et al.  Characterization of interleukin-11 receptor and protein tyrosine phosphorylation induced by interleukin-11 in mouse 3T3-L1 cells. , 1992, The Journal of biological chemistry.

[151]  S. Wong,et al.  Disturbances in the composition of plasma lipoproteins during gram-negative sepsis in the rat. , 1992, Biochimica et biophysica acta.

[152]  K. Feingold,et al.  Tumor necrosis factor-α, interleukin-1, and interferon alpha stimulate triglyceride synthesis in HepG2 cells , 1991 .

[153]  M. Peitsch,et al.  Clusterin (complement lysis inhibitor) forms a high density lipoprotein complex with apolipoprotein A-I in human plasma. , 1991, The Journal of biological chemistry.

[154]  K. Feingold,et al.  Effect of interleukin-1 on lipid metabolism in the rat. Similarities to and differences from tumor necrosis factor. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[155]  A. Bach,et al.  Decreased lipolytic activity in tissues during infectious and inflammatory stress. , 1991, Nutrition.

[156]  C. Stoner,et al.  Induction of phospholipase A2 gene expression in human hepatoma cells by mediators of the acute phase response. , 1991, The Journal of biological chemistry.

[157]  R. Krauss,et al.  Tumor necrosis factor acutely increases plasma levels of very low density lipoproteins of normal size and composition. , 1990, Endocrinology.

[158]  H. Harris,et al.  Human very low density lipoproteins and chylomicrons can protect against endotoxin-induced death in mice. , 1990, The Journal of clinical investigation.

[159]  K. Feingold,et al.  Diet affects the mechanisms by which TNF stimulates hepatic triglyceride production. , 1990, The American journal of physiology.

[160]  K. Feingold,et al.  Evidence for two classes of cytokines that stimulate hepatic lipogenesis: relationships among tumor necrosis factor, interleukin-1 and interferon-alpha. , 1990, Endocrinology.

[161]  W. Ettinger,et al.  Lipopolysaccharide and tumor necrosis factor cause a fall in plasma concentration of lecithin: cholesterol acyltransferase in cynomolgus monkeys. , 1990, Journal of lipid research.

[162]  I. Goldberg,et al.  Tumor necrosis factor induced release of endothelial cell lipoprotein lipase. , 1990, Arteriosclerosis.

[163]  H. Northoff,et al.  Inhibition of endotoxin-induced activation of human monocytes by human lipoproteins , 1989, Infection and immunity.

[164]  M. Serio,et al.  Multiple cytokines stimulate hepatic lipid synthesis in vivo. , 1989, Endocrinology.

[165]  J. Parks,et al.  Lipoprotein abnormalities associated with lipopolysaccharide-induced lecithin: cholesterol acyltransferase and lipase deficiency. , 1989, The Journal of biological chemistry.

[166]  F. Cambien,et al.  Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes , 1989, Diabetologia.

[167]  F. López‐Soriano,et al.  Interleukin-1 and lipid metabolism in the rat. , 1989, The Biochemical journal.

[168]  B. Forette,et al.  CHOLESTEROL AS RISK FACTOR FOR MORTALITY IN ELDERLY WOMEN , 1989, The Lancet.

[169]  K. Feingold,et al.  Effect of tumor necrosis factor administration in vivo on lipoprotein lipase activity in various tissues of the rat. , 1989, Journal of lipid research.

[170]  S. Hajduk,et al.  Lysis of Trypanosoma brucei by a toxic subspecies of human high density lipoprotein. , 1989, The Journal of biological chemistry.

[171]  D. Williamson,et al.  Increased rates of hepatic cholesterogenesis and fatty acid synthesis in septic rats in vivo: evidence for the possible involvement of insulin. , 1989, Clinical science.

[172]  S. Aust,et al.  Inhibition of superoxide and ferritin-dependent lipid peroxidation by ceruloplasmin. , 1989, The Journal of biological chemistry.

[173]  L. Bausserman,et al.  Serum amyloid A and high density lipoproteins during the acute phase response , 1988, European journal of clinical investigation.

[174]  K. Feingold,et al.  Mechanisms by which tumor necrosis factor stimulates hepatic fatty acid synthesis in vivo. , 1988, Journal of lipid research.

[175]  J. Levy,et al.  Neutralization of mouse xenotropic virus by lipoproteins involves binding to the virions. , 1988, The Journal of general virology.

[176]  W. Wilkinson,et al.  Changes in serum lipids in patients with condylomata acuminata treated with interferon alfa-n1 (Wellferon). , 1988, Journal of the American Academy of Dermatology.

[177]  J. Berliner,et al.  Low density lipoproteins transfer bacterial lipopolysaccharides across endothelial monolayers in a biologically active form. , 1988, The Journal of clinical investigation.

[178]  L. Chedid,et al.  Control of endotoxin activity and interleukin-1 production through regulation of lipopolysaccharide-lipoprotein binding by a macrophage factor , 1988, Infection and immunity.

[179]  G. Bagby,et al.  Triacylglycerol kinetics in endotoxic rats with suppressed lipoprotein lipase activity. , 1987, The American journal of physiology.

[180]  R. Havel.  Lipid transport function of lipoproteins in blood plasma. , 1987, The American journal of physiology.

[181]  J. Tavernier,et al.  Multiple effects of tumor necrosis factor on lipoprotein lipase in vivo. , 1987, The Journal of biological chemistry.

[182]  G. Howlett,et al.  Effect of acute inflammation on rat apolipoprotein mRNA levels , 1987, Inflammation.

[183]  M. Kawakami,et al.  Human recombinant TNF suppresses lipoprotein lipase activity and stimulates lipolysis in 3T3-L1 cells. , 1987, Journal of biochemistry.

[184]  B. Aggarwal,et al.  Interferons and tumor necrosis factors have similar catabolic effects on 3T3 L1 cells. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[185]  M. Kawakami,et al.  Lipid Metabolism in Endotoxic Rats , 1986, Microbiology and immunology.

[186]  R. Stearman,et al.  Transcriptional regulation of serum amyloid A gene expression. , 1986, The Journal of biological chemistry.

[187]  M. Brown,et al.  A receptor-mediated pathway for cholesterol homeostasis. , 1986, Science.

[188]  E. Benditt,et al.  Plasma clearance kinetics of the amyloid-related high density lipoprotein apoprotein, serum amyloid protein (apoSAA), in the mouse. Evidence for rapid apoSAA clearance. , 1983, The Journal of clinical investigation.

[189]  R. Munford,et al.  Sites of tissue binding and uptake in vivo of bacterial lipopolysaccharide-high density lipoprotein complexes: studies in the rat and squirrel monkey. , 1981, The Journal of clinical investigation.

[190]  A. Meinders,et al.  Strong decrease of high sensitivity C-reactive protein with high-dose atorvastatin in patients with type 2 diabetes mellitus. , 2003, Atherosclerosis.

[191]  C. Janeway,et al.  Innate immune recognition. , 2002, Annual review of immunology.

[192]  P. Wilson,et al.  Remnant-like particle (RLP) cholesterol is an independent cardiovascular disease risk factor in women: results from the Framingham Heart Study. , 2001, Atherosclerosis.

[193]  K. Werdan,et al.  Reduction of Circulating Cholesterol and Apolipoprotein Levels during Sepsis , 1999, Clinical chemistry and laboratory medicine.

[194]  A. Hamsten,et al.  Evidence for a role of tumor necrosis factor alpha in disturbances of triglyceride and glucose metabolism predisposing to coronary heart disease. , 1998, Metabolism: clinical and experimental.

[195]  J. Medalie,et al.  Isolated low HDL cholesterol as a risk factor for coronary heart disease mortality. A 21-year follow-up of 8000 men. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[196]  K. Feingold,et al.  Regulation of lipid metabolism by cytokines during host defense. , 1996, Nutrition.

[197]  H. Ginsberg.  Lipoprotein metabolism and its relationship to atherosclerosis. , 1994, The Medical clinics of North America.

[198]  W. Ettinger,et al.  Cytokines decrease apolipoprotein accumulation in medium from Hep G2 cells. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[199]  E. Levy,et al.  Circulating tumor necrosis factor-alpha levels and lipid abnormalities in patients with cystic fibrosis. , 1993, Pediatric research.

[200]  L. Chan,et al.  Endotoxin-induced hypertriglyceridemia is mediated by suppression of lipoprotein lipase at a post-transcriptional level. , 1993, Journal of lipid research.

[201]  W. Fiers,et al.  Stimulation of lipolysis in cultured fat cells by tumor necrosis factor, interleukin-1, and the interferons is blocked by inhibition of prostaglandin synthesis. , 1992, Endocrinology.

[202]  M. Kunitomo,et al.  A uniform alteration in serum lipid metabolism occurring during inflammation in mice. , 1992, Japanese journal of pharmacology.

[203]  E. Borden,et al.  Effects of interleukin-2 (IL-2) on human plasma lipid, lipoprotein, and C-reactive protein , 1990, Biotherapy.

[204]  S. Sabesin,et al.  Effects of the acute phase response on the concentration and density distribution of plasma lipids and apolipoproteins. , 1989, Journal of lipid research.

[205]  G. Utermann,et al.  Herpes simplex virus binds to human serum lipoprotein. , 1988, Intervirology.